Recall dermatitis caused by reexposition of docetaxel following irradiation of the brain. Case report and review of literature;Recall-dermatitis durch docetaxel-reexposition nach gehirnbestrahlung: Fallbeobachtung und literaturübersicht

Strahlentherapie und Onkologie

Volumn 177, Issue 9, 2001, Pages 487-493

  Giesel, Barbara U ^a   Kutz, Gudrun G ^a   Thiel, Hans Joachim ^a  

^a KLINIKUM BAMBERG   (Germany)

Author keywords

Docetaxel; Paclitaxel; Radiation recall; Toxicity

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; ANTIBIOTIC AGENT; ANTIMETABOLITE; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; HYDROXYUREA; IFOSFAMIDE; INTERLEUKIN 2; MERCAPTOPURINE; METHOTREXATE; PACLITAXEL; TAMOXIFEN; TAXANE DERIVATIVE; TIOGUANINE; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; VINDESINE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARCINOMATOUS MENINGITIS; CASE REPORT; DRUG REEXPOSURE; FEMALE; HUMAN; RADIATION DERMATITIS; RECALL;

EID: 0034849510     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00002431     Document Type: Article

References (35)

1. Docetaxel (Taxotere®) associated sclerodermia-like changes of the lower extremities
2. Taxotere®
3. Dermatotoxizität antineoplastischer substanzen
4. Paclitaxel-induced radiation recall dermatitis
5. Adriamycin-induced recall phenomenon 15 years after radiotherapy
6. Side effects of chemotherapy. Case 1. Radiation recall dermatitis from gemcitabine
7. Side effects of chemotherapy. Case 2. Radiation recall reaction induced by gemcitabine
8. Induction chemotherapy with Docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: A phase I/II trial
9. Docetaxel in head and neck cancer: A review
10. Phase II trial of Docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck
11. Allgemeine prinzipien der tumortherapie
12. Adriamycin activating a recall phenomenon after radiation therapy
13. Taxol® and radiation; studies in cooperative cytotoxioty using cells cultured in vitro. Proc 34th Annual ASTRO Meeting
14. Taxoide
15. Phase I study of Paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer
16. Combined radiochemotherapy with Docetaxel in patients with unresectable locally advanced head and neck tumors
17. Anthracyclines in the treatment of cancer. An overview
18. Combination chemotherapy with Docetaxel, cisplatin, and 5-fluorouracil in previously treated patients with advanced/recurrent head and neck cancer. A phase II feasibility study
19. Weekly Docetaxel and concomitant boost radiotherapy for non-small-cell-lung cancer. A phase I/II dose escalation trial
20. Concurrent conventionally fractionated radiotherapy and weekly Docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma
21. Phase I study of Docetaxel with concomitant thoracic radiation therapy
22. Paclitaxel-induced radiation recall dermatitis
23. Adjuvante und systemische therapie
24. New drugs - The taxoids: Paclitaxel (Taxol®) and Docetaxel (Taxotere®)
25. Radiation-recall dermatitis in a patient treated with Paclitaxel
26. Late effects of cancer treatment: Radiation and drug toxicity
27. Substanzprofile: Zytostatika, hormone, zytokine
28. Toxizität der Strahlentherpie
29. Docetaxel and Cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early CLinical Studies Group
30. Radiation recall, dermatitis and pneumonitis in a patient treated with Paclitaxel
31. Taxol®: A novel radiation sensitizer
32. Radiation-recall dermatitis with Docetaxel: EstabLishment of a requisite radiation threshold
33. Acute cutaneous reactions to Docetaxel, a new chemotherapeutic agent
34. Docetaxel and radiation-recall severe mucositis